Sorrento Therapeutics Investor Says Board Looted Company
An investor in Sorrento Therapeutics Inc. launched a derivative lawsuit in the Delaware Chancery Court on Thursday, accusing the clinical biopharmaceutical company's board members of stripping the firm of value to...To view the full article, register now.
Already a subscriber? Click here to view full article